In addition, CEBPD is thought to be a potent tumor suppressor, and its expression is downregulated in several cancers, including breast cancer [54], leukemia [55], cervical cancer [56], and hepatocellular carcinoma [57]. Here, CEBPD is linked to hepatocellular carcinoma.